|
Effect of initial serum AHSG level on the survival of patients with alcoholic liver cirrhosis throughout the 1-year observation period (A) and between months 1–12 (B) |
||||
| A |
||||
|
|
||||
| Deceased |
Survived |
Total |
Mortality rate % |
|
|
|
||||
| Serum AHSG < 365 μg/ml |
32 |
3 |
35 |
94.1 |
| Serum AHSG ≥ 365 μg/ml |
5 |
49 |
54 |
9.3 |
| Total |
37 |
52 |
89 |
|
| p < 0.001, Relative Risk: 9.874 (95% C.I.: 4.258 – 22.898) |
||||
|
|
||||
| B |
||||
|
|
||||
| Deceased |
Survived |
Total |
Mortality rate % |
|
|
|
||||
| Serum AHSG < 365 μg/ml |
18 |
3 |
21 |
85.7 |
| Serum AHSG ≥ 365 μg/ml |
5 |
49 |
54 |
9.3 |
| Total |
23 |
52 |
75 |
|
| p < 0.001, Relative Risk: 9.257 (95% C.I.: 3.945 – 21.724) |
||||
Kalabay et al. BMC Gastroenterology 2007 7:15 doi:10.1186/1471-230X-7-15 |
||||